BioScience Health Innovations, Inc. (BHIC)

AI-Powered SEC Filing Analysis

Quarterly Report Filed: 2026-05-11

Key Insights

  • Revenue declined 39% year-over-year in Q1 2026 ($751K vs $1.23M in Q1 2025), indicating significant business contraction and challenging market conditions for the company.
  • The company swung from profitability to a net loss of $230K in Q1 2026 despite gross margin remaining relatively stable at 65%, driven primarily by a 52% increase in operating expenses ($716K vs $469K).
  • Cash position improved to $1.15M from $662K at year-end 2025, but this is offset by new debt of $460K taken on during the quarter, suggesting potential liquidity stress requiring external financing.
  • Accounts receivable dropped dramatically from $399K to $78K while inventory increased 160% to $874K, raising concerns about sales conversion efficiency and potential inventory obsolescence risk.
  • As a non-accelerated filer and smaller reporting company with emerging growth status, BHIC has limited analyst coverage and institutional investor interest, which may contribute to limited capital availability.
Current Report Filed: 2026-04-02

Key Insights

  • The company has appointed Daniel Schmidt, the Chief Technology Officer, to its Board of Directors, indicating his growing influence and involvement in the company's strategic direction.
  • The departure of Justin Earl from the Board of Directors does not appear to be due to any disagreement with the company, suggesting it was an amicable transition.
  • Daniel Schmidt has extensive experience in therapeutic medical devices and treatments, which could help drive the company's product development and commercialization efforts.
Annual Report Filed: 2026-03-30

Key Insights

  • The company is an emerging growth company and has not been subject to all public reporting requirements, which could impact transparency and investor confidence.
  • The company has a history of losses and may need to raise additional capital in the future, which could lead to dilution for existing shareholders.
  • The company has identified cybersecurity as a key risk factor, indicating potential vulnerabilities that could impact operations and financial performance.

Get real-time filing analysis in the app

Download on the App Store

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.